ASCO issues guidelines for HR+ metastatic breast cancer
The American Society of Clinical Oncology has issued new guidelines for endocrine therapy for women with hormone receptor–positive metastatic breast cancer.
The consensus recommendations note that...
Source: Ob.Gyn. News - Category: OBGYN Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Hormones | OBGYN | Women